Colistin alone or combined with sulbactam or carbapenem against A. baumannii in ventilator-associated pneumonia

Creative Commons License

Yilmaz G. R. , Guven T., Guner R., Tufan Z. , Izdes S. , Tasyaran M. A. , ...More

Journal of Infection in Developing Countries, vol.9, no.5, pp.476-485, 2015 (Refereed Journals of Other Institutions) identifier identifier

  • Publication Type: Article / Article
  • Volume: 9 Issue: 5
  • Publication Date: 2015
  • Doi Number: 10.3855/jidc.6195
  • Title of Journal : Journal of Infection in Developing Countries
  • Page Numbers: pp.476-485


Introduction: Colistin use has increased over the last ten years because of multidrug-resistant microorganisms. The aim of this study was to compare the clinical and microbiological efficacy of colistin alone or in combination with sulbactam or carbapenem in the treatment of ventilator-associated pneumonia (VAP) due to multidrug-resistant (MDR) and extremely drug-resistant (XDR) A. baumannii.